NTLA
Intellia Therapeutics, IncData: 2026-09-11
Quick Stats
Sep 11, 202632.4
AI Score
SELL0.79
Volume Ratio
TBA
Next Earnings
13
+ve Days (30d)
15
-ve Days (30d)
NTLA Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
NTLA Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
NTLA Options - Sort by Max open Interest (near term)
11th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NTLA Daily Out of Money Options - Sort by Max open Interest (near term)
11th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NTLA Daily In the Money Options - Sort by Max open Interest (near term)
11th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NTLA Most Active Options by Volume(near term)
11th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NTLA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NTLA Stock Summary
Last updated Sep 11, 2026
NTLA is currently trading at $11.74, positioned below its 200-day moving average of $12.63, suggesting bearish momentum. The stock has a 52-week range of $7.95 to $28.25.
Technical Analysis: The 50-day moving average stands at $12.54, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.751, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.037, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NTLA at 32.4/100 with a SELL recommendation.
NTLA (Intellia Therapeutics, Inc) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.751 |
| CMF (20) | 0.037 |
| ROC (10) | -10.45 |
| ADX (14) | 14.279 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.04 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -96.135 |
| MFI (14) | 28.308 |
NTLA Candlestick Patterns
No validated candlestick patterns fired for NTLA in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Intellia Therapeutics, Inc is below both the 50 Day and 200 Day SMA which is considered Bearish.
NTLA Moving Averages Analysis
NTLA (Intellia Therapeutics, Inc) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 12.51 |
| 20 | 12.58 |
| 30 | 12.22 |
| 50 | 12.54 |
| 100 | 13.29 |
| 200 | 12.63 |
NTLA Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -3.34 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.1565 |
| EPS Estimate Next Year ($) | -2.599 |
| WallStreet Target Price ($) | 24.00 |
| Most Recent Quarter |
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.